ARYx Therapeutics, Inc.
6300 Dumbarton Circle
Fremont,
CA 94555
United States - Map
Phone: 510-585-2200
Fax: 510-585-2202
Web Site: http://www.aryx.com
| ARYx Therapeutics, Inc., a biopharmaceutical company, focuses on developing a portfolio of product candidates designed to eliminate known safety issues associated with commercial drugs using its RetroMetabolic Drug Design technology. Its product portfolio includes tecarfarin, an oral anticoagulant in Phase II/III clinical development for the treatment of patients who are at risk for the formation of dangerous blood clots; budiodarone/ATI-2042, an oral antiarrhythmic agent in Phase II clinical development for the treatment of atrial fibrillation, a form of irregular heartbeat; ATI-7505, an oral prokinetic agent in Phase II clinical development for the treatment of chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease; and ATI-9242, an antipsychotic agent in Phase I clinical development for the treatment of schizophrenia and other psychiatric disorders. The company also involves in the preclinical development of ATI-20,000 and ATI-24,000, which focus on metabolic and gastrointestinal disorders. ARYx Therapeutics, Inc. was incorporated in 1997 and is based in Fremont, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Paul Goddard Ph.D., 60
Chairman and Chief Exec. Officer |
$
437.00K |
$
79.00K | Dr. Peter G. Milner M.D., 54
Co-Founder, Pres of R&D |
$
323.00K | N/A | Dr. Pascal Druzgala Ph.D., 56
Co-Founder, Chief Scientific Officer and Sr. VP |
$
270.00K | N/A | Mr. John Varian , 50
Chief Operating Officer and Chief Financial Officer |
$
314.00K | N/A | Dr. Daniel M. Canafax Pharm.D., 58
Chief Devel. Officer and VP |
$
263.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.35% Nasdaq 
Profile
